Table 1.
Stimulus | Cell Type | Concentration/Incubation * | Readout |
---|---|---|---|
Endothelial Cells | |||
Proinflammatory stimuli | |||
IL1α | HUVEC | 5 ng/mL 0–72 h |
Annexin V binding; TF and endothelial antigen expression; procoagulant effects in vivo [35,36] |
IL1β | HUVEC | 10 U/mL 24 h |
EV release and marker antigen expression [37] |
LPS | HAEC | 10 ng/mL 24 h |
EV release; PS and annexin V expression [38] |
PMA | HUVEC | 100 ng/mL 24 h |
EV release [37] |
TNFα | Renal and brain microvascular and coronary artery macrovascular ECs | 10 ng/mL 24 h |
Marker antigen expression and annexin V binding [39] |
TNFα | HUVEC | 10 ng/mL 24 h |
TF release by small and large EVs [40] |
TNFα | HUVEC | 1–100 ng/mL 6 h (blebbing) 24 h (vesiculation) |
EV release and marker antigen expression; procoagulant activity in vitro [37] |
TNFα | HUVEC | 100 ng/mL 48 h |
MP release [41] |
TNFα | HBMEC | 20 ng/mL 20 h |
MP release [42] |
TNFα | HMEC-1 | 100 ng/mL 48 h |
MP release [43] |
Procoagulant stimuli | |||
Ca2+ ionophore A23187 | HUVEC | 100 µmol/L 10 min |
EV release [37] |
Complement C5b-9 | HUVEC | 2 µg in 125 µL 10 min |
EV release; prothrombinase and thrombomodulin activity [44] |
PAI-1 | HUVEC | 1–10 ng/mL 1–3 h |
Procoagulant, uPAR and integrin αvβ3 expression, thrombin generation [44,45,46] |
Thrombin | HUVEC | 0.1–10 U/mL 24–48 h |
Marker antigen expression; procoagulant MP release [37,47,48] |
Thrombin | HBMEC | 2 U/mL 20 h |
Procoagulant MP release [42] |
Proapoptotic stimuli | |||
Serum and growth factor deprivation | Renal and brain microvascular ECs; coronary artery macrovascular ECs | N/A 24 h |
Marker antigen expression and annexin V binding [39] |
Staurosporine | HUVEC | 100 nmol/L 2–16 h |
Apoptotic MP/PS exposure; annexin V binding; TF expression; factor Xa activation [49] |
Platelets | |||
Ca2+ ionophore A23187 | Human platelets | 10 µM 15 min |
CD62P and PS exposure, EV quantity and quality [45,46] |
ABT-737 | Human platelets | 30 µM 90 min |
CD62P and PS exposure [50] |
ADP | Human platelets | 60 µM 30 min |
EV quantity and quality [45] |
ADP | Human platelets | 20 µM 1 h |
EV quantity and quality [51] |
Collagen | Human platelets | 10 µg/mL 30 min |
EV generation [45,52] |
Complement C5b-9 | Human platelets | 2 µg in 125 µL 10 min |
EV release, factor V binding [7] |
CRP-XL | Human platelets | 1 µg/mL 30 min |
EV generation [45,52] |
LPS | Human platelets | 100 ng/mL 3 h |
EV quantity and quality [45] |
Thrombin | Human platelets | 1 U/mL 15 min |
CD62P and PS exposure [50] |
Thrombin | Human platelets | 1 U/mL 30 min |
EV generation [45,52] |
Thrombin and CaCl2 | Human platelets | 0.25 U/mL 5 min |
EV quantity and quality [53] |
TRAP6 | Human platelets | 60 µM 30 min |
EV quantity and quality [45] |
Monocytes | |||
Ca2+ ionophore A23187 | THP-1 | 10 mM 5 min |
TF+ MP release [37,54] |
LPS | THP-1 | 5 µg/mL 4 h |
MP release [55] |
LPS | THP-1 | 1 µg/mL 1 h (RT) |
MP release [56] |
LPS | THP-1 | 1 µg/mL 5 h (RT) |
TF+ MP release [54] |
* Incubation at 37 °C, if not stated otherwise.